UK Lags in Cancer Treatment Wait Times, Affecting Survival Rates

A study reveals that UK cancer patients face longer waits for chemotherapy and radiotherapy compared to those in Canada, Norway, and Australia, highlighting a need for improved cancer care.

Cancer patients in the UK experience longer waits for chemotherapy and radiotherapy compared to those in Canada, Norway, and Australia, affecting their chances of survival.
The UK has lower proportions of cancer patients receiving chemotherapy and radiotherapy, with older patients being the least likely to receive treatment.
Research funded by Cancer Research UK and conducted by University College London highlights the UK's lag in cancer treatment times and utilization across eight cancer types.
The NHS workforce crisis and lack of long-term government planning on cancer are cited as major barriers to timely cancer treatment in the UK.
Improvements in cancer survival rates in other countries are attributed to shorter treatment wait times and greater use of chemotherapy and radiotherapy.